Souche

2022

Publications

• Activity of Exebacase (CF-301) against Biofilms Formed by Staphylococcus epidermidis Strains Isolated from Prosthetic Joint Infections

2021

Publications

• Past and Future of Phage Therapy and Phage-Derived Proteins in Patients with Bone and Joint Infection
• Evaluation of intraosteoblastic activity of dalbavancin against Staphylococcus aureus in an ex vivo model of bone cell infection
• Arthroscopic « Debridement and Implant Retention » With Local Administration of Exebacase (Lysin CF-301) Followed by Suppressive Tedizolid as Salvage Therapy in Elderly Patients for Relapsing Multidrug-Resistant S. epidermidis Prosthetic Knee Infection

Posters

• Phage discovery: isolation and characterization of seventeen novel anti-Staphylococcus aureus bacteriophages

2020

Posters

• Arthroscopic Debridement Antibiotic And Implant Retention (DAIR) with local administration of Exebacase (Lysin CF-301) (LysinDAIR) followed by suppressive tedizolid as salvage therapy in elderly patients for relapsing multidrug-resistant Staphylococcus epidermidis prosthetic knee infection